Compare StocksABBV vs PH

AbbVie Inc. (ABBV) vs Parker-Hannifin Corporation (PH): Which Is the Better Buy in 2026?

As of 2026-06-19, ABBV is overvalued at $216, with a DCF intrinsic value of $160 and a margin of safety of -35%. PH is overvalued at $953, with an intrinsic value of $663 and a margin of safety of -44%. Of the two, ABBV has the wider margin of safety.

ABBV
AbbVie Inc.
$216.49
VS
PH
Parker-Hannifin Corporation
$953.27

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
PH
  • Parker-Hannifin Corporation has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Parker-Hannifin Corporation scores 84/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
  • Free cash flow has grown at a 14.7% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 5.4% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 105.6x is 69% above the historical average of 62.3x — the stock trades at a premium to its own history.
PH
  • FCF yield of 2.3% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • PEG ratio of 3.67 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • 28 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

Key Valuation Metrics

Learn more →
ABBV
PH
Valuation
$20.81B
Free Cash Flow
$2.77B
5.44%
FCF Yield
2.31%
105.60
Trailing P/E
35.15
13.32
Forward P/E
27.96
Quality & Moat
21.89%
ROIC
14.75%
N/A
ROE
24.84%
72.03%
Gross Margin
37.44%
0.61
PEG Ratio
3.67
Balance Sheet Safety
N/A
Net Debt / Equity
0.62
N/A
Interest Coverage
N/A
2.12
Net Debt / EBITDA
1.66
3.11%
Dividend Yield
0.76%
ABBV: 7Ties: 1PH: 2
ABBVPH

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

PH

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PH
$12.10
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$6.11B
Δ Market Cap
+$73.94B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
35.3% Overvalued
Price is 35.3% above estimated fair value
Current Price: $216.49
Fair Value: $160.05
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PH
43.7% Overvalued
Price is 43.7% above estimated fair value
Current Price: $953.27
Fair Value: $663.35
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $216?

+17.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +17.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.7%, reflecting heavy growth investment.

PH

What growth rate is the market pricing in at $953?

+14.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +19.2%

The market implies +14.2% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +19.2%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
PH
84/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
PH
-2.48
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,106
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PH
Insiders 0.2%Institutions 91.2%Retail & Other 8.6%
No. of Institutional Holders2,504
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
PH
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PH
0
Sells (3M)
28
Sells (12M)
Total value (12M): $46.28M
BRACHT BEREND
Officer
$1.13M
@ $1002.13 · 2026-02-13
BENDALI RACHID
Officer
$414,777
@ $1006.74 · 2026-02-13
SCOTT PATRICK M.
Officer
$818,889
@ $983.06 · 2026-02-12
HART MARK J
Officer
$2.83M
@ $1009.12 · 2026-02-12
GENTILE THOMAS C.
Officer
$1.33M
@ $1001.51 · 2026-02-12
ROSS ANDREW D.
President
$4.66M
@ $999.00 · 2026-02-11
LEOMBRUNO TODD M.
Chief Financial Officer
$2.07M
@ $1002.34 · 2026-02-11
PARMENTIER JENNIFER A
Chief Executive Officer
$4.69M
@ $996.66 · 2026-02-11
BRACHT BEREND
Officer
$1.38M
@ $946.48 · 2026-02-02
JACOBSON MATTHEW A.
Officer
$535,766
@ $949.94 · 2026-02-02
PAREL DINU JOHN
Chief Technology Officer
$1.25M
@ $950.05 · 2026-02-02
IVES ANGELA R
Officer
$1.02M
@ $952.30 · 2026-01-30
GENTILE THOMAS C.
Officer
$2.24M
@ $941.31 · 2026-01-30
ROSS ANDREW D.
Chief Operating Officer
$2.23M
@ $894.81 · 2025-12-11
BRACHT BEREND
Officer
$3.03M
@ $864.58 · 2025-11-12
BENDALI RACHID
Officer
$1.23M
@ $852.99 · 2025-11-12
REIDY JAY
Officer
$337,675
@ $863.62 · 2025-11-12
VERRIER JAMES R.
Director
$1.13M
@ $750.00 · 2025-09-02
LEONTI JOSEPH R.
General Counsel
$3.47M
@ $750.84 · 2025-08-25
PAREL DINU JOHN
Chief Technology Officer
$817,477
@ $741.14 · 2025-08-12
BRACHT BEREND
Officer
$202,506
@ $728.44 · 2025-08-08
SCOTT PATRICK M.
Officer
$1.15M
@ $729.45 · 2025-08-08
JACOBSON MATTHEW A.
Officer
$421,510
@ $733.06 · 2025-08-08
ROSS ANDREW D.
President
$3.20M
@ $732.66 · 2025-08-08
HART MARK J
Officer
$1.65M
@ $730.22 · 2025-08-08
GENTILE THOMAS C.
Officer
$826,524
@ $729.50 · 2025-08-08
IVES ANGELA R
Officer
$589,162
@ $727.36 · 2025-08-08
MALONE ROBERT W
Officer
$1.65M
@ $730.66 · 2025-08-08
REIDY JAY
Officer
$335,783
@ $675.62 · 2025-05-19
REIDY JAY
Officer
$93,056
@ $620.37 · 2025-05-02
CZAJA MARK T.
Chief Technology Officer
$266,948
@ $711.86 · 2025-01-31
BRACHT BEREND
Officer
$1.08M
@ $699.29 · 2024-11-06
ROSS ANDREW D.
Chief Operating Officer
$3.43M
@ $706.04 · 2024-11-06
HART MARK J
Officer
$2.79M
@ $705.40 · 2024-11-06
GENTILE THOMAS C.
Officer
$1.70M
@ $701.16 · 2024-11-06
PAREL DINU JOHN
Officer
$1.23M
@ $699.39 · 2024-11-06
MALONE ROBERT W
Officer
$2.76M
@ $700.24 · 2024-11-06
PARMENTIER JENNIFER A
Chief Executive Officer
$3.46M
@ $704.69 · 2024-11-06
VERRIER JAMES R.
Director
$825,981
@ $635.37 · 2024-11-04
LEONTI JOSEPH R.
General Counsel
$3.71M
@ $631.04 · 2024-11-01
IVES ANGELA R
Officer
$118,773
@ $635.15 · 2024-11-01
BRACHT BEREND
Officer
$503,982
@ $592.92 · 2024-08-26
PARMENTIER JENNIFER A
Chief Executive Officer
$1.55M
@ $588.59 · 2024-08-22
ROSS ANDREW D.
President
$1.90M
@ $588.58 · 2024-08-16
BENDALI RACHID
Officer
$1.04M
@ $574.86 · 2024-08-14
HART MARK J
Officer
$1.17M
@ $566.23 · 2024-08-09
GENTILE THOMAS C.
Officer
$583,536
@ $567.09 · 2024-08-09
PAREL DINU JOHN
Chief Technology Officer
$807,685
@ $571.61 · 2024-08-09
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PH
FearGreed
😏Greed(68/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
PH
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (68)
View ABBV Full AnalysisView PH Full Analysis

Frequently Asked Questions: ABBV vs PH

Is AbbVie Inc. or Parker-Hannifin Corporation more undervalued in 2026?

Based on our discounted cash flow model, ABBV trades at a -35.3% margin of safety (intrinsic value $160 vs. price $216), compared to PH's -43.7% margin of safety (intrinsic $663 vs. $953).

Which stock has a wider economic moat, AbbVie Inc. or Parker-Hannifin Corporation?

PH scores 84/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. PH scores 6.4 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, AbbVie Inc. or Parker-Hannifin Corporation?

AbbVie Inc. (ABBV) generates a 5.4% free cash flow yield, compared to Parker-Hannifin Corporation's 2.3%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, AbbVie Inc. or Parker-Hannifin Corporation?

ABBV earns 21.9% ROIC versus PH's 14.7%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Parker-Hannifin Corporation's?

PH's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). PH has raised its dividend for 3 consecutive years.

ABBV vs PH: Which Is the Better Buy in 2026? | SafetyMargin.io